Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10032216 | American Journal of Obstetrics and Gynecology | 2005 | 7 Pages |
Abstract
A suboptimal cytoreduction confers no survival advantage to women with advanced ovarian cancer. Thus, these patients may be the best candidates for initial chemotherapy, and identifying them preoperatively becomes important.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Elise N. MD, Cara C. MD, Lisa M. PhD, Willie A. MD, Laurel W. MD, William P. MD, Peyton T. MD,